Novo Capital Expenditures from 2010 to 2026

NVOS Stock  USD 0  0.0004  12.90%   
Novo Integrated Capital Expenditures yearly trend continues to be comparatively stable with very little volatility. Capital Expenditures is likely to outpace its year average in 2026. From the period from 2010 to 2026, Novo Integrated Capital Expenditures quarterly data regression had r-value of  0.12 and coefficient of variation of  80.09. View All Fundamentals
 
Capital Expenditures  
First Reported
2005-02-28
Previous Quarter
K
Current Value
K
Quarterly Volatility
32.4 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Novo Integrated financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novo Integrated's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.1 M, Selling General Administrative of 17 M or Other Operating Expenses of 26.1 M, as well as many indicators such as Price To Sales Ratio of 0.11, Dividend Yield of 0.0 or PTB Ratio of 16.85. Novo financial statements analysis is a perfect complement when working with Novo Integrated Valuation or Volatility modules.
  
Build AI portfolio with Novo Stock
Check out the analysis of Novo Integrated Correlation against competitors.

Latest Novo Integrated's Capital Expenditures Growth Pattern

Below is the plot of the Capital Expenditures of Novo Integrated Sciences over the last few years. Capital Expenditures are funds used by Novo Integrated Sciences to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Novo Integrated operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software. It is Novo Integrated's Capital Expenditures historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novo Integrated's overall financial position and show how it may be relating to other accounts over time.
Capital Expenditures10 Years Trend
Pretty Stable
   Capital Expenditures   
       Timeline  

Novo Capital Expenditures Regression Statistics

Arithmetic Mean81,053
Geometric Mean63,895
Coefficient Of Variation80.09
Mean Deviation48,019
Median54,982
Standard Deviation64,916
Sample Variance4.2B
Range243.8K
R-Value0.12
Mean Square Error4.4B
R-Squared0.02
Significance0.64
Slope1,588
Total Sum of Squares67.4B

Novo Capital Expenditures History

202661 K
202556.6 K
202249.2 K
2021190.2 K
2020255.9 K
201912.1 K
2018107.6 K

About Novo Integrated Financial Statements

Novo Integrated shareholders use historical fundamental indicators, such as Capital Expenditures, to determine how well the company is positioned to perform in the future. Although Novo Integrated investors may analyze each financial statement separately, they are all interrelated. The changes in Novo Integrated's assets and liabilities, for example, are also reflected in the revenues and expenses on on Novo Integrated's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Capital Expenditures56.6 K61 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Novo Stock Analysis

When running Novo Integrated's price analysis, check to measure Novo Integrated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Integrated is operating at the current time. Most of Novo Integrated's value examination focuses on studying past and present price action to predict the probability of Novo Integrated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Integrated's price. Additionally, you may evaluate how the addition of Novo Integrated to your portfolios can decrease your overall portfolio volatility.